Sol-M Slip Tip Syringe without Needle, Sol-M Eccentric Tip Syringe without Needle
K242099 · Sol-Millennium Medical, Inc. · FMF · Oct 22, 2024 · General Hospital
Device Facts
Record ID
K242099
Device Name
Sol-M Slip Tip Syringe without Needle, Sol-M Eccentric Tip Syringe without Needle
Applicant
Sol-Millennium Medical, Inc.
Product Code
FMF · General Hospital
Decision Date
Oct 22, 2024
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 880.5860
Device Class
Class 2
Attributes
Therapeutic
Intended Use
The syringe without needle is used to inject fluids into, or withdraw fluids from, the body.
Device Story
The Sol-M Slip Tip and Eccentric Tip Syringes are sterile, single-use, 3-piece manual piston syringes. They consist of a polypropylene barrel and plunger with a polyisoprene rubber piston, lubricated with polydimethylsiloxane. The device is operated manually by a clinician to inject or withdraw fluids. It is available in various volumes (1ml to 60ml) and features Luer slip connectors. The device is EO sterilized. By providing a sterile, reliable means for fluid transfer, the syringe facilitates medication delivery or sample collection, benefiting patients by ensuring accurate dosing and maintaining sterility during clinical procedures.
Clinical Evidence
No clinical data. Bench testing only, including compliance with ISO 7886-1 (syringe performance), ISO 80369-7/20 (connector performance), ISO 10993 series (biocompatibility), USP <788> (particulate matter), and ASTM F88/F1929 (packaging integrity).
Technological Characteristics
3-piece manual piston syringe. Materials: Polypropylene (barrel/plunger), Polyisoprene rubber (piston), Polydimethylsiloxane (lubricant). Sterilization: Ethylene Oxide (EO) to 10-6 SAL. Standards: ISO 7886-1, ISO 80369-7, ISO 80369-20, ISO 10993-1/4/5/7/10/11, ISO 11135, USP <788>, ASTM F88/F88M-15, ASTM F1929-15. Connectivity: None (manual).
Indications for Use
Indicated for use in patients requiring injection of fluids into or withdrawal of fluids from the body.
Regulatory Classification
Identification
A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.
Predicate Devices
Sterile Hypodermic Syringes for Single Use (K221079)
K210227 — Sterile syringe for single use with/without needle · Zhejiang Kangkang Medical-Devices Co., Ltd. · Sep 10, 2021
K221079 — Sterile Hypodermic Syringes for Single Use · Sichuan Prius Biotechnology Co., Ltd. · Oct 4, 2022
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA text logo on the right. The FDA text logo is in blue and includes the acronym "FDA" followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in a stacked format.
October 22, 2024
Sol-Millennium Medical Inc. % Amy Li, Technology Director Shanghai Mind-link Consulting Co., Ltd. Room A08, Floor 14th, No 699, Jiaozhou Rode Jing'an District, Shanghai, Shanghai 201803, China
## Re: K242099
Trade/Device Name: Sol-MIM Slip Tip Syringe without Needle, Sol-MTM Eccentric Tip Syringe without Needle Regulation Number: 21 CFR 880.5860 Regulation Name: Piston Syringe Regulatory Class: Class II Product Code: FMF Dated: June 27, 2024 Received: September 27, 2024
## Dear Amy Li:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
{1}------------------------------------------------
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review. the OS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
{2}------------------------------------------------
Sincerely,
# Shruti N. Mistry -S
Shruti Mistry Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices, and Human Factors OHT3: Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
# Indications for Use
510(k) Number (if known) K242099
#### Device Name
Sol-M™ Slip Tip Syringe without Needle Sol-M™ Eccentric Tip Syringe without Needle
#### Indications for Use (Describe)
The syringe without needle is used to inject fluids into, or withdraw fluids from, the body.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
#### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{4}------------------------------------------------
Image /page/4/Picture/0 description: The image shows the logo for SolM, which is a company that is building a healthier tomorrow. The logo consists of a green half circle, an orange circle, the word "SolM" in green, and the words "Building a Healthier Tomorrow" in a smaller font. The logo is simple and modern, and it conveys the company's mission of improving health.
# K242099 510(k) Summary
- 1. Date of preparation: October 22, 2024
- 2. Submitter information
Address: 311 S Wacker Drive, Suite 4100, Chicago, Illinois, 60606, United States Contact person: Manu Kalia, Global QARA Director, +1 847-313-9577, mkalia@solm.com Submission correspondent: Amy.li, Technology director, +86 15721449974, amy.li@mind-link.net
- 3. Subject Device
Trade name: Sol-M™ Slip Tip Syringe without Needle, Sol-M™ Eccentric Tip Syringe without Needle Common name: Piston Syringe Regulation: 21 CFR § 880.5860 Product code: FMF Classification: Class II Review Pannel: General Hospital
- 4. Predicate Device
K221079 Trade Name: Sterile Hypodermic Syringes for Single Use Regulation Number: 21 CFR 880.5860 Regulation Name: Piston Syringe Regulatory Class: Class II Product Code: FMF Review Panel: General hospital
- 5. Indication for use statement
The syringe without needle is used to inject fluids into, or withdraw fluids from, the body
- 6. Device description
The Slip Tip and Eccentric Tip Syringe without Needle is a sterile, single-use, standard 3 piece piston. The device is packed individually and EO sterilized with 10-6 SAL.
- 6.1 The proposed device includes different specifications.
- 1ml Slip Tip Syringe without Needle
- 3ml Slip Tip Syringe without Needle
- 5ml Slip Tip Syringe without Needle
- 10ml Slip Tip Syringe without Needle
- 20ml Slip Tip Syringe without Needle
- 30ml Slip Tip Syringe without Needle
- 60ml Slip Tip Syringe without Needle
- 10ml Eccentric Tip Syringe without Needle
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the logo for Sol M. The logo consists of a green half circle, an orange circle, the text "Sol M" in green, and the text "Building a Healthier Tomorrow" in a smaller font size. The text "Sol M" is in a bold, sans-serif font. The logo is simple and modern.
- 20ml Eccentric Tip Syringe without Needle
- 60ml Eccentric Tip Syringe without Needle
- 6.2 Label requirement
- The label shall meet the requirements of 21 CFR Part 801
- 7. Comparison of technological characteristics with the predicate devices
The subject device has the same intended use, technology, and design; and performance specifications are either identical or substantially equivalent to existing legally marketed predicate devices. The differences between the subject device and predicate devices do not alter suitability of the proposed device for its intended use.
| Item | Proposed Device Slip Tip Syringe<br>without Needle, Eccentric Tip<br>Syringe without Needle | Predicate Device Sterile Hypodermic<br>Syringes for Single Use<br>K221079 | Remark |
|-------------------------------------------|----------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------|
| Indication for Use | The syringe without needle is<br>used to inject fluids into, or<br>withdraw fluids from, the body. | The Sterile Hypodermic Syringes for Single<br>Use are intended to be used for medical<br>purpose to inject fluid into or withdraw<br>fluid from body. | Same |
| Prescription or OTC<br>(over the counter) | Prescription use | Prescription use | Same |
| Configuration | Barrel | Barrel | Same |
| Configuration | Plunger | Plunger | Same |
| Configuration | Piston | Piston | Same |
| Operation Mode | For manual use only | For manual use only | Same |
| Single Use | Single Use | Single Use | Same |
| Syringe<br>performance | Complied with ISO 7886-1 | Complied with ISO 7886-1 | Same |
| Luer Connector<br>Performance | Complied with ISO 80369-7 | Complied with ISO 80369-7 | Same |
| Volume | Slip tip:1ml, 3ml, 5ml, 10ml,<br>20ml, 30ml, 60ml<br>Eccentric tip: 10ml, 20ml, 60ml | 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 30ml,<br>50ml, 60ml, 100ml | Similar.<br>Analysis 1 |
| Connector Type | Luer slip(Slip tip, Eccentric tip) | Luer slip/Luer lock | Similar.<br>Analysis 2 |
| Barrel | Polypropylene(PP) | Polypropylene(PP) | Same |
| Plunger | Polypropylene(PP) | Polypropylene(PP) | Same |
| Piston | Polyisoprene rubber(IR) | Polyisoprene | Same |
| Lubricant | Polydimethylsiloxane | Polydimethylsiloxane | Same |
| Sterilization | EO Sterilized | EO Sterilized | Same |
| Shelf life | 5 years | 5 years | Same |
{6}------------------------------------------------
Image /page/6/Picture/0 description: The image shows the logo for Sol M, a company focused on building a healthier tomorrow. The logo features a green dot, an orange circle, and the text "Sol M" in a dark green, sans-serif font. To the right of "Sol M" are the words "Building a Healthier Tomorrow" in a smaller, lighter font.
#### Analvsis 1:Volume
The subject device has less volume compared with the predicate device. but the predicate device has additional volumes 2ml and 100ml. However, all syringe performance was tested in accordance with ISO 7886-1 and ISO 80369-7. Therefore, this difference in syringe volume will not affect the Substantial Equivalence (SE) between the proposed device and the predicate device.
#### Analysis 2: Connector Type
The subject device has the same connector type compared with the predicate device, but the predicate device has an additional Luer lock type. However, the Luer connector performance complies with ISO 80369-7. Therefore, this difference in connector type will not affect the Substantial Equivalence (SE) between the proposed device and the predicate device.
#### 8. Non-clinical Performance Testing
Non-clinical tests were conducted to verify that the proposed device meets all design specifications. The test results demonstrated that the proposed device complies with the following standards:
- 8.1 ISO 7886-1:2017 Sterile hypodermic syringes for single use- Part 1: Syringes for manual use.
- 8.2 ISO 80369-7:2021 Small-bore connectors for liquids and gases in healthcare application -- Part 7: Connectors for intravascular or hypodermic application
- 8.3 ISO 80369-20:2015 Small-bore connectors for liquids and gases in healthcare applications - Part 20: Common test methods
- 8.4 ISO 10993-1:2018 Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process
- 8.5 ISO 10993-4:2017 Biological evaluation of medical devices Part 4: Selection of tests for interactions with blood
- 8.6 ISO 10993-5:2009 Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity
- 8.7 ISO 10993-7:2008 Biological evaluation of medical devices Part 7: Ethylene oxide sterilization residuals
- 8.8 ISO 10993-10: 2010 Biological evaluation of medical devices Part 10: Tests for irritation and skin sensitization
- 8.9 ISO 10993-11:2017 Biological evaluation of medical devices Part 11: Tests for systemic toxicity
- 8.10 USP <788> Particulate Matter for injection
- 8.11 ISO 11135:2014 Sterilization of health-care products Ethylene oxide Requirements for the development, validation and routine control of a sterilization process for medical devices
- 8.12ASTM F88/F88M-15, Standard Test Method For Seal Strength Of Flexible Barrier Materials
- 8.13 ASTM F1929-15 Standard Test Method for Detecting Seal Leaks in Porous Medical Package by Dye Penetration
{7}------------------------------------------------
Image /page/7/Picture/0 description: The image is a logo for Sol M, a company that is building a healthier tomorrow. The logo features a green circle with a portion cut out, an orange circle, and the text "Sol M" in green. To the right of the "M" is the text "Building a Healthier Tomorrow" in a smaller font.
### 9. Clinical Testing
No clinical study is included in this submission.
- 10.Conclusion
The differences between the predicate and the subject device do not raise any new or different questions of safety or effectiveness. The subject device is substantially equivalent to the predicate device Sterile Hypodermic Syringes for Single Use (K221079).
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.